Immunologic Factors: all 3,292 studies that test it
Page 23 of 33. Open to participants first (386), then studies with results posted, then the rest; newest registration first within each.
- Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell LymphomaCompletedNCT02086604Phase 1
- Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT02077959Phase 1
- Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular LymphomaCompletedNCT02063685Phase 3
- Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)Status unknownNCT02060656Phase 2
- Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell LymphomaCompletedNCT02049541Phase 1
- Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE and CyclophosphamideCompletedNCT02046915Phase 2
- Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal InsufficiencyCompletedNCT02045017Phase 2
- Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and ImmunochemotherapyCompletedNCT02042391Phase 2
- Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory ConditionsWithdrawnNCT02042027Phase 1
- Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple MyelomaTerminatedNCT02030483Phase 1
- Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT02029950Phase 1
- Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic AnaemiaStatus unknownNCT02028416Not applicable
- Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCTStatus unknownNCT02027064Phase 4
- Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung CancerTerminatedNCT02018523Phase 1
- Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and AdolescentsStatus unknownNCT02014506Phase 1/2
- Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIbCompletedNCT02012088Phase 2
- Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaActive, not recruitingNCT02007044Phase 2
- Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLLCompletedNCT02005289Phase 2
- A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple MyelomaCompletedNCT01998971Phase 1
- Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic AnemiaStatus unknownNCT01997372Phase 4
- Preemptive Therapy of GVHDTerminatedNCT01994824Phase 2
- IVIG Treatment for Asthmatic Patients With IgG Subclass DeficiencyStatus unknownNCT01992328Phase 3
- Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With DLBCL: a Phase II Multicenter Study of the FILStatus unknownNCT01990144Phase 2
- A Phase 1 QT Study in Healthy Male SubjectsCompletedNCT01986894Phase 1
- Pharmacokinetics and Safety of IVIG Nanogam 100 mg/mlCompletedNCT01985373Phase 3
- Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood TransplantationStatus unknownNCT01983761Phase 1/2
- Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe PemphigusStatus unknownNCT01974518Phase 3
- A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple MyelomaCompletedNCT01965353Phase 1
- Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System LymphomaCompletedNCT01956695Phase 2
- Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin LymphomaActive, not recruitingNCT01955499Phase 1
- Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous NephropathyCompletedNCT01955187Phase 3
- Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple MyelomaTerminatedNCT01954784Phase 1
- LIME Study (LFB IVIg MMN Efficacy Study)CompletedNCT01951924Phase 3
- Rituximab + GM-CSF in Patients With Follicular B-Cell LymphomaCompletedNCT01939730Phase 2
- Thymoglobulin in Cadaver DonorCompletedNCT01939171Phase 2
- Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)CompletedNCT01936532Phase 2
- Rituximab Maintenance Therapy in Aggressive CD20 (Cluster of Differentiation Antigen 20) Positive Lymphoma and Mantle Cell LymphomaStatus unknownNCT01933711Phase 3
- GP2013 in Japanese Patients With CD20 Positive Low Tumor Burden Indolent B-cell Non-Hodgkin's LymphomaCompletedNCT01933516Phase 1
- Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT01904643Phase 1
- An Efficacy and Tolerability Study of Bortezomib in Combination With Rituximab Standard Therapy in Participants With Relapsed or Refractory Follicular LymphomaTerminatedNCT01902862Phase 2
- Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin LymphomaTerminatedNCT01900496Phase 1
- Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT01886859Phase 1
- PK and PD Study of Natalizumab in Pediatric Subjects With RRMSCompletedNCT01884935Phase 1
- ATG in Haploidentical HSCT for Acute Graft-versus-host Disease ProphylaxisCompletedNCT01883180Phase 4
- Leukine (Sargramostim) for Parkinson's DiseaseCompletedNCT01882010Phase 1
- Ibrutinib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Older Patients With Newly Diagnosed Mantle Cell LymphomaActive, not recruitingNCT01880567Phase 2
- Long-Term Efficacy and Safety of CT-P10 in Patients With RACompletedNCT01873443Phase 1
- Sargramostim for Myeloid Dendritic Cell DeficiencyCompletedNCT01871467Phase 1
- Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)CompletedNCT01868269Phase 3
- The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/SepsisTerminatedNCT01867645Phase 1
- R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCLCompletedNCT01865110Phase 3
- Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILDCompletedNCT01862926Phase 2/3
- Treatment for Advanced B-Cell LymphomaCompletedNCT01859819Phase 2
- Anti-thymocyte Globulins for Graft-versus-host Disease ProphylaxisCompletedNCT01856803Phase 4
- Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHLCompletedNCT01851551Phase 1/2
- Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.CompletedNCT01845584Phase 2
- Randomised Study Comparing Different Dosages of Rabbit ATG in Patients With SAAStatus unknownNCT01844635Phase 3
- Rituximab for Anti-cytokine Autoantibody-Associated DiseasesCompletedNCT01842386Phase 1
- Study to Evaluate Pharmacokinetics of Pomalidomide in Hepatically Impaired MalesCompletedNCT01835561Phase 1
- BR in Patients With CLL With Comorbidities and/or Renal DysfunctionCompletedNCT01832922Phase 1
- Lenalidomide Plus Rituximab (R) in Non Follicular NHLStatus unknownNCT01830478Phase 2
- VELCADE® Plus Rituximab in Non Hodgkin's Follicular LymphomaCompletedNCT01830465Phase 2
- Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase TherapyActive, not recruitingNCT01829958Not applicable
- Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular LymphomaActive, not recruitingNCT01829568Phase 1
- Subcutaneous Ig Maintenance Therapy for Myasthenia GravisTerminatedNCT01828294Phase 1
- Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.CompletedNCT01827072Phase 3
- Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II MelanomaWithdrawnNCT01826864Phase 3
- Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.CompletedNCT01824251Phase 3
- Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS SyndromeCompletedNCT01816620Phase 2
- T&B Depletion Non MalignantStatus unknownNCT01810926Phase 2
- Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)CompletedNCT01808911Phase 3
- Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT LymphomaActive, not recruitingNCT01808599Phase 2
- First in Human Study of an Anti-Toll-like Receptor 4 (TLR4) Monoclonal Antibody (NI-0101) in Adult Healthy VolunteersCompletedNCT01808469Phase 1
- Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL AmyloidosisTerminatedNCT01807286Phase 1
- A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.CompletedNCT01789099Phase 1/2
- Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell LymphomasCompletedNCT01788189Phase 1/2
- Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's MacroglobulinemiaCompletedNCT01788020Phase 3
- IVIG Treatment in Systemic SclerosisStatus unknownNCT01785056Not applicable
- A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate CancerCompletedNCT01784913Phase 1/2
- Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins LymphomaCompletedNCT01775631Phase 1
- Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus NephritisTerminatedNCT01773616Phase 3
- Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDASWithdrawnNCT01769027Phase 2
- A Phase IB Study Of The BTKi CC-292 Combined With Lenalidomide In Adults Patients With Relapsed/Refractory B-Cell LymphomaCompletedNCT01766583Phase 1
- Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus NephropathyTerminatedNCT01765842Phase 3
- Study of Sonographic Efficacy of Rituximab in Rheumatoid ArthritisCompletedNCT01765374Phase 4
- Dose Adjusted EPOCH-R, to Treat Mature B Cell MalignanciesCompletedNCT01760226Early Phase 1
- Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic AnemiaStatus unknownNCT01759732Phase 2
- Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid ArthritisCompletedNCT01759030Phase 3
- Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell CarcinomaTerminatedNCT01758458Phase 1/2
- Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple MyelomaCompletedNCT01758328Phase 1
- Intravenous Gammaglobulin for Sickle Cell Pain CrisesCompletedNCT01757418Phase 1/2
- Ipilimumab and Lenalidomide in Advanced CancerCompletedNCT01750983Phase 1
- Lenalidomide After Allo TransplantTerminatedNCT01750762Phase 1
- SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM PatientsCompletedNCT01749969Phase 1
- Rituximab in Systemic SclerosisCompletedNCT01748084Phase 2/3
- Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)CompletedNCT01745640Phase 2
- Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid MalignanciesTerminatedNCT01744912Phase 1
- Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCompletedNCT01744626Phase 1
- An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)TerminatedNCT01742793Phase 1
- Bendamustine/Lenalidomide/Rituximab: Combination as a Second-Line Therapy for 1st Relapsed-Refractory MCLCompletedNCT01737177Phase 2